Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.276
Neutral
RSI(14)
43.332
Neutral
STOCH(KDJ)(9,3,3)
41.275
Sell
ATR(14)
0.628
High Vlolatility
CCI(14)
-89.122
Neutral
Williams %R
62.282
Sell
TRIX(12,20)
0.067
Sell
StochRSI(14)
5.366
Oversold
Koninklijke Philips NV
PHG27.320USD
+0.050+0.18%
Close 10/31, 16:00（ET）Quotes delayed by 15 min
25.97BMarket Cap
134.26P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Koninklijke Philips NV
Currency: USD Updated: 2025-10-31Key Insights
The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Koninklijke Philips NV's Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
2
analysts
Buy
Current Rating
28.650
Target Price
+5.06%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Koninklijke Philips NV Highlights
StrengthsRisks
Koninklijke Philips NV is a Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others.
Industry Leader
The company's revenue leads the industry, with the latest annual revenue totaling USD 19.49B.
Overvalued
The company’s latest PE is 148.18, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 51.58M shares, decreasing 24.79% quarter-over-quarter.
Held by Brandes Investmen
Star Investor Brandes Investmen holds 1.53M shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.19.
Financial Health
Currency: USD Updated: 2025-10-31The company's current financial score is 8.87, which is higher than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 4.92B, representing a year-over-year increase of 2.36%, while its net profit experienced a year-over-year increase of 43.97%.
Score
Financials
5.68
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
No Data
Quality of Earnings
9.00
Operational Efficiency
10.00
Growth Potential
9.93
Shareholder Returns
9.76
Koninklijke Philips NV's Company Valuation
Currency: USD Updated: 2025-10-31The company’s current valuation score is 6.01, which is lower than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is 148.18, which is 6.19% below the recent high of 157.35 and 157.68% above the recent low of -85.47.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 52/210
No Data
Earnings Forecast
Currency: USD Updated: 2025-10-31The company’s current earnings forecast score is 8.00, which is higher than the Healthcare Equipment & Supplies industry's average of 7.74. The average price target for Koninklijke Philips NV is 28.65, with a high of 30.30 and a low of 27.00.
Score
Support & Resistance
No Data
Analyst Rating
Based on
2
analysts
Buy
Current Rating
28.650
Target Price
+5.06%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
89
Total
4
Median
7
Average
Company name
Ratings
Analysts
Koninklijke Philips NV
PHG
2
Boston Scientific Corp
BSX
36
Edwards Lifesciences Corp
EW
35
Intuitive Surgical Inc
ISRG
34
Veeva Systems Inc
VEEV
33
Thermo Fisher Scientific Inc
TMO
30
1
2
3
...
18
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
No Data
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2025-10-31The company’s current price momentum score is 7.21, which is higher than the Healthcare Equipment & Supplies industry's average of 6.65. Sideways: Currently, the stock price is trading between the resistance level at 29.03 and the support level at 25.87, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
27.676
Sell
MA10
28.165
Sell
MA20
28.022
Sell
MA50
27.854
Sell
MA100
26.493
Buy
MA200
25.879
Buy
Institutional Confidence
Currency: USD Updated: 2025-10-31The company’s current institutional recognition score is 3.00, which is lower than the Healthcare Equipment & Supplies industry's average of 6.43. The latest institutional shareholding proportion is 5.43%, representing a quarter-over-quarter decrease of 12.51%. The largest institutional shareholder is Sarah Ketterer, holding a total of 1.85M shares, representing 0.19% of shares outstanding, with 14.94% increase in holdings.
Score
Institutional Shareholding
No Data
Shareholder Activity
Name
Shares Held
Chg %
Fiduciary Management, Inc.
Mondrian Investment Partners Ltd.
Dimensional Fund Advisors, L.P.
Fidelity Management & Research Company LLC
Parametric Portfolio Associates LLC
Northern Trust Global Investments
Envestnet Asset Management, Inc.
Connor, Clark & Lunn Investment Management Ltd.
1
2
Risk Assessment
Currency: USD Updated: 2025-10-31The company’s current risk assessment score is 8.92, which is higher than the Healthcare Equipment & Supplies industry's average of 4.56. The company's beta value is 0.82. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.
Score
Beta vs S&P 500 index
0.82
VaR
+3.28%
240-Day Maximum Drawdown
+24.26%
240-Day Volatility
+31.23%
Return
Best Daily Return
60 days
+3.28%
120 days
+9.20%
5 years
+26.77%
Worst Daily Return
60 days
-5.50%
120 days
-5.50%
5 years
-15.95%
Sharpe Ratio
60 days
+0.89
120 days
+1.21
5 years
+0.09
Risk Assessment
Maximum Drawdown
240 days
+24.26%
3 years
+33.81%
5 years
+80.77%
Return-to-Drawdown Ratio
240 days
+0.25
3 years
+1.06
5 years
-0.12
Skewness
240 days
-0.42
3 years
+3.30
5 years
+1.78
Volatility
Realised Volatility
240 days
+31.23%
5 years
+37.62%
Standardised True Range
240 days
+1.93%
5 years
+2.17%
Downside Risk-Adjusted Return
120 days
+180.38%
240 days
+180.38%
Maximum Daily Upside Volatility
60 days
+16.10%
Maximum Daily Downside Volatility
60 days
+24.21%
Liquidity
Average Turnover Rate
60 days
+0.11%
120 days
+0.11%
5 years
--
Turnover Deviation
20 days
-19.34%
60 days
+7.96%
120 days
+10.52%
Peer Comparison
Healthcare Equipment & Supplies
Koninklijke Philips NV
PHG
7.35 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cencora Inc
COR
8.56 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Boston Scientific Corp
BSX
8.51 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Artivion Inc
AORT
8.48 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Castle Biosciences Inc
CSTL
8.47 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Hologic Inc
HOLX
8.47 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
